Replies to post #96964 on Bioelectronics Corp (BIEL)

[HORUS]

You won't get one till sales start poring in.

[uksausage]

the problem with a share buy back is that it takes money.

if we assume Q1 2017 actually breaks even there is a lot of things that have to be done with any spare cash.

IF a major licensing deal is done with up front payments then some of that could be used for share buy back but day to day profits once they start to flow should be put into advertising and product development/studies.

I also expect that a share buy back in will cost a lot on admin fees which again could be better spent on advertising.

A R/S of 10:1 cold be presented in pure share structure light once we turn profitable - news which itself will keep us heading up. but again that costs admin fees.

we are not yet profitable, we will be with the USA market now beginning to be addressed.

A clear strategy communicated on how the USA market is t be entered - distribution deals, licensing deals online, QVC etc will enable shareholders to hold on to their shares as things are rolled out along with product roadmap - what is their position with Allay and RecoveryRx. If they get general muscular skeleton clearance will they need to continue with trials for say BPH?

I will continue to acquire down at these prices and probably for another 500% gain before considering when to start profiting.

[4toSchool]

I've heard that a stock share buys back are for executives who can't come up with ideas to earn a better profit for the company. A buyback could hinder the sales growth of Biel, which is where the real money is to be made. Whether through stock valuation growth or a buyout, BIEL needs sales, and a lot of them. IMHO they need to invest money into the company's growth versus a buyback